Position in BIIB
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$233,560
+$18,205 QoQ
Shares Held
1,081
+42.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#726
of 1,031 holders
Holding Since
Sep 2021
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026EADS & HEALD WEALTH MANAGEMENT holds $8,527,198 across 7 Drug Manufacturers - General names. BIIB ranks #6 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
7,028 | $2,544,979 | |
| 2 | JNJ |
Johnson & Johnson
|
8,955 | $2,274,301 | |
| 3 | LLY |
ELI LILLY & Co
|
1,461 | $1,752,367 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
18,330 | $1,056,174 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
3,532 | $446,232 | |
| 6 | BIIB |
Biogen Inc.
This page
|
1,081 | $233,560 | |
| 7 | PFE |
Pfizer Inc
|
9,119 | $219,585 |
All Filings in BIIB
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $233,560 | 1,081 | Shares | Sole | 2026-07-31 | |
| 2021-09-30 | $215,355 | 761 | Shares | Sole | 2021-10-27 | |
| No filing history on record for this holder in this stock. | ||||||